Alnylam Pharmaceuticals Ratios and Metrics

Market cap in millions MXN. Fiscal year is January - December.

Millions MXN. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug '25 Aug 29, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	726,495	632,425	406,090	570,313	415,790	300,466
Market Cap Growth	-0.06%	55.73%	-28.79%	37.16%	38.38%	24.07%
Enterprise Value	727,332	631,299	410,448	576,677	407,412	291,285
Last Close Price	8380.00	4900.00	3227.45	4682.29	3880.27	2750.00
PS Ratio	12.34	13.50	13.14	28.18	24.02	30.64
PB Ratio	169.34	452.40	-108.87	-184.79	34.48	14.86
P/TBV Ratio	169.34	452.40	-	-	34.48	14.86
P/FCF Ratio	178.93	-	572.67	-	-	-
P/OCF Ratio	148.98	-	230.62	-	-	-
EV/Sales Ratio	13.19	13.48	13.28	28.50	23.54	29.70
EV/FCF Ratio	179.13	-	578.81	-	-	-
Debt / Equity Ratio	11.86	40.89	-12.16	-16.51	3.72	1.57
Debt / FCF Ratio	12.53	-	63.96	-	-	-
Asset Turnover	0.71	0.56	0.50	0.29	0.24	0.17
Inventory Turnover	6.83	3.86	2.85	1.57	1.74	1.19
Quick Ratio	2.37	2.61	2.86	3.17	3.79	4.23
Current Ratio	2.54	2.78	3.08	3.51	4.04	4.47
Return on Equity (ROE)	32.73%	-	-	-526.14%	-106.31%	-69.92%
Return on Assets (ROA)	3.65%	-2.74%	-4.78%	-13.65%	-12.56%	-17.85%
Return on Capital Employed (ROCE)	8.00%	-5.80%	-9.90%	-28.30%	-24.00%	-29.40%
Earnings Yield	0.11%	-0.92%	-1.83%	-3.87%	-4.21%	-5.68%
FCF Yield	0.56%	-0.14%	0.18%	-2.10%	-3.54%	-4.54%
Buyback Yield / Dilution	-4.82%	-2.20%	-2.64%	-2.73%	-3.01%	-5.24%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.